820960713	820960713	CD	B-NP	O
|	|	NN	I-NP	O
BH	BH	NN	I-NP	O
|	|	NN	I-NP	O
08510916	08510916	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9312052	9312052	CD	B-NP	O
|	|	CC	I-NP	O
1/22/2006	1/22/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
|	|	NN	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/22/2006	1/22/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/9/2007	2/9/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
BARENDS	BARENDS	NNS	B-NP	O
,	,	,	O	O
REGINALD	REGINALD	NNP	B-NP	O
MD	MD	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Dizziness	Dizziness	NN	B-NP	O
,	,	,	I-NP	O
weakness	weakness	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
82-year-old	82-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	I-NP	O
angio	angio	NN	I-NP	O
interventions	intervention	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
returning	return	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
weak	weak	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
sensation	sensation	NN	I-NP	O
as	as	IN	B-SBAR	O
if	if	IN	I-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
die	die	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
burning	burn	VBG	I-NP	O
sensation	sensation	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
mid	mid	JJ	I-NP	O
sternum	sternum	NN	I-NP	O
and	and	CC	O	O
upper	upper	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
lightheaded	lightheade	VBN	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
worse	worse	JJR	B-ADJP	O
when	when	WRB	B-ADVP	O
lying	lie	VBG	B-VP	O
flat	flat	JJ	B-ADJP	O
and	and	CC	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
intermittent	intermittent	JJ	B-NP	O
nausea	nausea	NN	I-NP	O
without	without	IN	B-PP	O
vomiting	vomit	VBG	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
radiation	radiation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
many	many	JJ	B-NP	O
recent	recent	JJ	I-NP	O
HTN	HTN	NN	I-NP	O
episodes	episode	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
w/associated	w/associate	VBN	I-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
prompting	prompt	VBG	B-VP	O
many	many	JJ	B-NP	O
visits	visit	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Caea	Caea	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
about	about	RB	B-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
ago	ago	IN	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Bayi	Bayi	NNP	I-NP	O
for	for	IN	B-PP	O
similar	similar	JJ	B-NP	O
complaints	complaint	NNS	I-NP	O
with	with	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
urgency	urgency	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
workup	workup	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
cold	cold	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
vision	vision	NN	B-NP	O
,	,	,	O	O
numbness	numbness	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
melena	melena	NN	B-NP	O
or	or	CC	O	O
urinary	urinary	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
152	152	CD	B-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

Fingerstick	Fingerstick	JJ	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
report	report	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
100s	100	NNS	I-NP	O
recently	recently	RB	B-ADVP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
complaint	complaint	JJ	B-ADJP	O
with	with	IN	B-PP	O
all	all	DT	B-NP	O
her	her	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
CABG	CABG	NN	B-NP	B-protein
x2	x2	NN	I-NP	I-protein
with	with	IN	B-PP	O
redo	redo	NN	B-NP	O
sternotomy	sternotomy	NN	I-NP	O
both	both	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1970s	1970s	CD	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
1990s	1990s	CD	I-NP	I-DNA
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
renal	renal	JJ	B-NP	O
stent	stent	JJ	I-NP	O
,	,	,	I-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
carotid	carotid	NN	I-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
1.25	1.25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
-LRB-	-LRB-	IN	B-PP	O
recently	recently	RB	B-ADVP	O
increased	increase	VBN	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
dose	dose	NN	I-NP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
last	last	JJ	I-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Swe	Swe	NNP	I-NP	O
Rehabilitation	Rehabilitation	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Of	Of	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
and	and	CC	I-NP	O
Lipitor	Lipitor	NN	I-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NN	B-NP	B-protein
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
rash	rash	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Identified	Identify	VBN	B-VP	O
as	as	IN	B-PP	O
noncontributory	noncontributory	JJ	B-ADJP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
retired	retired	JJ	I-NP	O
nurse	nurse	NN	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
worked	work	VBN	I-VP	O
in	in	IN	B-PP	O
Tecoll	Tecoll	NNP	B-NP	O
Rehabilitation	Rehabilitation	NNP	I-NP	O
Health	Health	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
four	four	CD	B-NP	O
children	child	NNS	I-NP	O
who	who	WP	B-NP	O
are	be	VBP	B-VP	O
alive	alive	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
living	live	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
remote	remote	JJ	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
or	or	CC	I-NP	O
illicit	illicit	JJ	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
59	59	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
136/58	136/58	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
describes	describe	VBZ	B-VP	O
as	as	IN	B-PP	O
elderly	elderly	JJ	B-NP	O
lying	lie	VBG	I-NP	O
supine	supine	NN	I-NP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
resting	rest	VBG	B-VP	O
comfortably	comfortably	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
awake	awake	JJ	B-ADJP	O
,	,	,	O	O
speaking	speak	VBG	B-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
,	,	,	I-NP	O
normocephalic	normocephalic	JJ	I-NP	O
and	and	CC	I-NP	O
atraumatic	atraumatic	JJ	I-NP	O
,	,	,	I-NP	O
anicteric	anicteric	JJ	I-NP	O
sclerae	sclerae	NNS	I-NP	O
,	,	,	O	O
mucous	mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
are	be	VBP	B-VP	O
moist	moist	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
supple	supple	NN	B-NP	O
without	without	IN	B-PP	O
lymphadenopathy	lymphadenopathy	NN	B-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
7-8	7-8	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
bibasilar	bibasilar	JJ	B-NP	O
fine	fine	JJ	I-NP	O
rales	rale	NNS	I-NP	O
with	with	IN	B-PP	O
fair	fair	JJ	B-NP	O
aeration	aeration	NN	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
rhonchi	rhonchi	NN	I-NP	O
or	or	CC	I-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
,	,	,	I-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
with	with	IN	B-PP	O
bradycardic	bradycardic	JJ	B-NP	O
rate	rate	NN	I-NP	O
at	at	IN	B-PP	O
48	48	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
.	.	.	O	O

Abdomen	Abdomen	NNP	B-NP	O
has	have	VBZ	B-VP	O
many	many	JJ	B-NP	O
old	old	JJ	I-NP	O
healed	healed	JJ	I-NP	O
scars	scar	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rashes	rash	NNS	I-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
without	without	IN	B-PP	O
hepatosplenomegaly	hepatosplenomegaly	NN	B-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
are	be	VBP	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
2	2	CD	I-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedal	pedal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Skin	Skin	NNP	B-NP	O
is	be	VBZ	B-VP	O
intact	intact	JJ	B-ADJP	O
without	without	IN	B-PP	O
rash	rash	NN	B-NP	O
.	.	.	O	O

Neuro	Neuro	RB	B-ADVP	O
,	,	,	O	O
cranial	cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
II	II	CD	B-NP	O
to	to	TO	B-PP	O
XII	XII	CD	B-NP	O
intact	intact	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Vascular	Vascular	JJ	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
bilateral	bilateral	JJ	B-NP	O
femoral	femoral	JJ	I-NP	O
bruits	bruit	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
audible	audible	JJ	B-ADJP	O
with	with	IN	B-PP	O
stethoscope	stethoscope	NN	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
140	140	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.5	4.5	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
108	108	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
23	23	CD	I-NP	O
,	,	,	O	O
anion	anion	NN	B-NP	O
gap	gap	NN	I-NP	O
of	of	IN	B-PP	O
9	9	CD	B-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9	9	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.8	1.8	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.7	0.7	CD	I-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
165	165	CD	I-NP	I-protein
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
not	not	RB	O	O
elevated	elevated	JJ	B-NP	O
,	,	,	I-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
6.91	6.91	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
35.9	35.9	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
227	227	CD	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
12.1	12.1	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
43.2	43.2	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.0	1.0	CD	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
portable	portable	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
with	with	IN	B-PP	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
with	with	IN	B-PP	O
rate	rate	NN	B-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
with	with	IN	B-PP	O
T-wave	T-wave	JJ	B-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
V5	V5	NN	I-NP	O
and	and	CC	I-NP	O
V6	V6	NN	I-NP	B-protein
,	,	,	O	O
leads	lead	VBZ	B-VP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
and	and	CC	I-NP	O
AVF	AVF	NN	I-NP	B-protein
.	.	.	O	O

All	All	DT	B-NP	O
present	present	JJ	I-NP	O
on	on	IN	B-PP	O
prior	prior	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

EMERGENCY	EMERGENCY	NN	B-NP	O
ROOM	ROOM	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Systolic	Systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
190s	190s	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
aspirin	aspirin	NN	B-NP	O
x1	x1	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
x1	x1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
went	go	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
170s	170s	CD	B-NP	O
prior	prior	JJ	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
transfer	transfer	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
by	by	IN	B-PP	O
serial	serial	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
abnormal	abnormal	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
1/28	1/28	CD	B-NP	O
She	She	NNP	I-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	I-NP	O
Plavix	Plavix	NN	I-NP	O
and	and	CC	I-NP	O
Lipitor	Lipitor	NN	I-NP	O
.	.	.	O	O

Fasting	Fast	VBG	B-NP	O
lipids	lipid	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
indicate	indicate	VB	I-VP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
statin	statin	NN	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
3/1	3/1	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
only	only	JJ	I-NP	O
hypertensive	hypertensive	JJ	I-NP	O
event	event	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
new	new	JJ	B-NP	O
flipped	flipped	JJ	I-NP	O
Ts	T	NNS	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
V3	V3	NN	I-NP	O
and	and	CC	I-NP	O
V4	V4	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
which	which	WDT	B-NP	O
happened	happen	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
on	on	IN	B-PP	O
6/3	6/3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
medical	medical	JJ	I-NP	O
team	team	NN	I-NP	O
suspects	suspect	VBZ	B-VP	O
hypertensive-induced	hypertensive-induced	JJ	B-NP	O
microvascular	microvascular	JJ	I-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
rule	rule	NN	I-NP	O
out	out	IN	B-PP	O
MI	MI	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
re-initiated	re-initiated	JJ	B-ADJP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
in	in	IN	B-PP	O
progress	progress	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
&	&	CC	I-NP	O
B	B	NN	I-NP	B-protein
set	set	NN	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Pump	Pump	NNP	B-NP	O
:	:	:	O	O
Echocardiogram	Echocardiogram	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Dallnorm	Dallnorm	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
10/6	10/6	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
1-2	1-2	NN	B-NP	O
+	+	SYM	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
tricuspid	tricuspid	NN	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mild	mild	JJ	B-NP	B-protein
pulmonary	pulmonary	JJ	I-NP	I-protein
hypertension	hypertension	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
43	43	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
fine	fine	JJ	B-NP	O
rales	rale	NNS	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
admit	admit	NN	I-NP	O
exam	exam	NN	I-NP	O
with	with	IN	B-PP	O
BNP	BNP	NN	B-NP	B-protein
of	of	IN	B-PP	O
160	160	CD	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
10/6	10/6	CD	B-NP	O
at	at	IN	B-PP	O
Warden	Warden	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
her	her	PRP	B-NP	O
Lisinopril	Lisinopril	NNP	I-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
15	15	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	VBN	B-VP	O
to	to	TO	B-VP	O
facilitate	facilitate	VB	I-VP	O
better	good	JJR	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
arise	arise	VB	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
and	and	CC	O	O
Lasix	Lasix	NNP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
3/1	3/1	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
began	begin	VBD	B-VP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
receiving	receive	VBG	I-VP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
see	see	VBP	B-VP	O
heme	heme	NN	B-NP	B-protein
below	below	IN	B-PP	O
of	of	IN	B-PP	O
more	more	JJR	B-NP	O
details	detail	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
transfusion	transfusion	NN	I-NP	O
was	be	VBD	B-VP	O
265	265	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
current	current	JJ	I-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
titrate	titrate	VB	I-VP	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
to	to	TO	B-VP	O
affect	affect	VB	I-VP	O
as	as	RB	B-ADVP	O
long	long	RB	I-ADVP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	O	O
climb	climb	NN	B-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
bradycardia	bradycardia	NN	I-NP	O
with	with	IN	B-PP	O
rates	rate	NNS	B-NP	O
ranging	range	VBG	B-VP	O
45-58	45-58	CD	B-NP	O
until	until	IN	B-PP	O
5/3	5/3	CD	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
130s	130s	CD	B-NP	O
to	to	TO	B-PP	O
140s	140s	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
effectively	effectively	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
25mg	25mg	NN	I-NP	O
x1	x1	NN	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
x2	x2	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
diltiazem	diltiazem	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
x1	x1	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
later	later	RB	B-VP	O
then	then	RB	I-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/8	6/8	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
12-22	12-22	JJ	I-NP	O
symptomatic	symptomatic	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
pause	pause	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
consulting	consulting	NN	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Siebel	Siebel	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
was	be	VBD	B-VP	O
notified	notify	VBN	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	I-NP	O
ventricular	ventricular	JJ	I-NP	O
pause	pause	NN	I-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Pinet	Pinet	NNP	I-NP	O
recommended	recommend	VBD	B-VP	O
starting	start	VBG	I-VP	O
an	an	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
load	load	NN	I-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
implemented	implement	VBN	I-VP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
in	in	IN	B-PP	O
progress	progress	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
no	no	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
EP	EP	NN	I-NP	O
eval	eval	NN	I-NP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
symptomatic	symptomatic	JJ	I-NP	O
pauses	pause	NNS	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Selma	Selma	NNP	I-NP	O
deferring	defer	VBG	B-VP	O
decision	decision	NN	B-NP	O
and	and	CC	I-NP	O
arrangements	arrangement	NNS	I-NP	O
for	for	IN	B-PP	O
Holter	Holter	NNP	B-NP	O
versus	versus	IN	B-PP	O
loop	loop	NN	B-NP	O
monitors	monitor	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
outpatient	outpatient	NN	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Baldrige	Baldrige	NNP	I-NP	O
According	According	NNP	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
cath	cath	NN	I-NP	O
reports	report	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
lifelong	lifelong	NNP	B-NP	O
Plavix	Plavix	NNP	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Stayrook	Stayrook	NNP	I-NP	O
's	's	POS	B-NP	O
preference	preference	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
thromboembolic	thromboembolic	JJ	B-NP	B-protein
prophylatic	prophylatic	JJ	I-NP	I-protein
Coumadin	Coumadin	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
paroxysmals	paroxysmal	NNS	B-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
discontinue	discontinue	VB	I-VP	O
the	the	DT	B-NP	O
aspirin	aspirin	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
possible	possible	JJ	B-NP	O
bleeding	bleed	VBG	I-NP	O
risk	risk	NN	I-NP	O
on	on	IN	B-PP	O
combination	combination	NN	B-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
deferring	defer	VBG	I-VP	O
this	this	DT	B-NP	O
decision	decision	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
outpatient	outpatient	NN	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
Pressure	Pressure	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
consultation	consultation	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Miehe	Miehe	NNP	I-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
hypertension	hypertension	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
recurrence	recurrence	NN	B-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/27/07	10/27/07	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
Doppler	Doppler	NNP	I-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
significant	significant	JJ	B-NP	O
re-stenosis	re-stenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
an	an	DT	B-NP	O
angioplasty	angioplasty	JJ	I-NP	O
and	and	CC	I-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
without	without	IN	B-PP	O
peri-procedure	peri-procedure	JJ	B-NP	O
complication	complication	NN	I-NP	O
aside	aside	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
blood	blood	NN	I-NP	O
loss	loss	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
as	as	IN	B-SBAR	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
described	describe	VBN	I-VP	O
in	in	IN	B-PP	O
heme	heme	NN	B-NP	B-protein
section	section	NN	I-NP	I-protein
below	below	IN	B-PP	I-protein
-RRB-	-RRB-	NN	B-NP	I-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
hypoproliferative	hypoproliferative	JJ	I-NP	O
normocytic	normocytic	JJ	I-NP	O
normochromic	normochromic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
identified	identify	VBN	B-VP	O
by	by	IN	B-PP	O
iron	iron	NN	B-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
B12	B12	NN	I-NP	B-protein
and	and	CC	I-NP	O
folate	folate	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/8	11/8	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
drop	drop	NN	I-NP	O
from	from	IN	B-PP	O
30-26	30-26	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
either	either	CC	O	O
a	a	DT	B-NP	O
lab	lab	NN	I-NP	O
variant	variant	NN	I-NP	O
or	or	CC	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
blood	blood	NN	B-NP	O
loss	loss	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
Lovenox	Lovenox	NN	I-NP	O
injections	injection	NNS	I-NP	O
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
team	team	NN	I-NP	O
decided	decide	VBD	B-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
TEDs	TED	NNS	B-NP	O
alone	alone	RB	B-ADVP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ambulatory	ambulatory	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/28	10/28	CD	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
post-angio	post-angio	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
lethargy	lethargy	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
post-procedure	post-procedure	JJ	I-NP	O
crit	crit	NN	I-NP	O
drop	drop	NN	I-NP	O
from	from	IN	B-PP	O
30-25	30-25	CD	B-NP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
repeat	repeat	NN	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
25	25	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hemodynamics	hemodynamic	NNS	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
stable	stable	JJ	B-ADJP	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
her	her	PRP$	B-NP	O
leg	leg	NN	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Angiography	Angiography	NNP	I-NP	O
Team	Team	NNP	I-NP	O
advised	advise	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
drop	drop	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
as	as	IN	B-PP	O
result	result	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
loss	loss	NN	I-NP	O
from	from	IN	B-PP	O
recent	recent	JJ	B-NP	O
angio	angio	NN	I-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Angio	Angio	NNP	I-NP	O
Team	Team	NNP	I-NP	O
advised	advise	VBD	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
to	to	TO	B-VP	O
pursue	pursue	VB	I-VP	O
imaging	image	VBG	I-VP	O
to	to	TO	I-VP	O
search	search	VB	I-VP	O
for	for	IN	B-PP	O
source	source	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
loss	loss	NN	I-NP	O
unless	unless	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
further	further	JJ	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
drop	drop	NN	I-NP	O
or	or	CC	O	O
unless	unless	IN	B-SBAR	O
she	she	PRP	B-NP	O
develops	develop	VBZ	B-VP	O
leg	leg	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
and	and	CC	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
2units	2unit	VBZ	B-VP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
only	only	RB	B-ADVP	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
symptomatic	symptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
bag	bag	NN	I-NP	O
was	be	VBD	B-VP	O
hung	hang	VBN	I-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
see	see	VBP	B-VP	O
cardiovascular	cardiovascular	JJ	B-NP	O
pump	pump	NN	I-NP	O
section	section	NN	I-NP	O
above	above	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

Post-transfusion	Post-transfusion	NN	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
30.1	30.1	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
blood	blood	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
needed	need	VBN	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
agents	agent	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
team	team	NN	I-NP	O
implemented	implement	VBD	B-VP	O
the	the	DT	B-NP	O
Gatea	Gatea	NNP	I-NP	O
Insulin	Insulin	NNP	I-NP	O
Diabetic	Diabetic	NNP	I-NP	O
Protocol	Protocol	NNP	I-NP	O
using	use	VBG	B-VP	O
NPH	NPH	NN	B-NP	B-protein
basal	basal	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
and	and	CC	O	O
pre-prandial	pre-prandial	JJ	B-NP	O
aspart	aspart	NN	I-NP	O
scales	scale	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
A1c	A1c	NN	I-NP	O
was	be	VBD	B-VP	O
6.8	6.8	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
nutrition/renal	nutrition/renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
essentially	essentially	RB	B-NP	O
stable	stable	JJ	I-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
from	from	IN	B-PP	O
7/28/28	7/28/28	CD	B-NP	O
was	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
medication-induced	medication-induced	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
likely	likely	RB	B-ADJP	O
from	from	IN	B-PP	O
recent	recent	JJ	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
dose	dose	NN	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
last	last	JJ	B-NP	O
GCGH	GCGH	NN	I-NP	O
admit	admit	NN	I-NP	O
,	,	,	O	O
and/or	and/or	CC	O	O
dehydration	dehydration	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
was	be	VBD	B-VP	O
and	and	CC	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
were	be	VBD	B-VP	O
both	both	DT	B-NP	O
held	held	NN	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
and	and	CC	I-NP	O
ACE	ACE	NN	I-NP	O
were	be	VBD	B-VP	O
both	both	DT	O	O
restarted	restart	VBD	B-VP	O
on	on	IN	B-PP	O
3/1	3/1	CD	B-NP	O
-LRB-	-LRB-	HYPH	O	O
see	see	VBP	B-VP	O
cardiovascular	cardiovascular	JJ	B-NP	O
section	section	NN	I-NP	O
above	above	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
:	:	:	O	O
During	During	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
reported	report	VBN	I-VP	O
crampy	crampy	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
medical	medical	JJ	I-NP	O
team	team	NN	I-NP	O
suspects	suspect	VBZ	B-VP	O
possible	possible	JJ	B-NP	O
cause	cause	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
ischemia	ischemia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
celiac	celiac	JJ	I-NP	O
disease	disease	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
MRA	MRA	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
at	at	IN	B-PP	O
Palmtial	Palmtial	NNP	B-NP	O
in	in	IN	B-PP	O
10/13	10/13	CD	B-NP	O
All	All	DT	B-NP	O
stool	stool	NN	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
as	as	IN	B-PP	O
on	on	IN	B-PP	O
9/6	9/6	CD	B-NP	O
her	her	PRP$	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

MISC	MISC	NN	B-NP	O
:	:	:	O	O
After	After	IN	B-PP	O
a	a	DT	B-NP	O
lengthy	lengthy	JJ	I-NP	O
discussion	discussion	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
opted	opte	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
DNI	DNI	NN	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
wanted	want	VBD	B-VP	O
all	all	DT	B-NP	O
other	other	JJ	I-NP	O
resuscitative	resuscitative	JJ	I-NP	O
measures	measure	NNS	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
82-year-old	82-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
intermittent	intermittent	JJ	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
and	and	CC	O	O
sudden	sudden	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
chest	chest	NN	I-NP	O
and	and	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
urgency	urgency	NN	I-NP	O
with	with	IN	B-PP	O
documented	document	VBN	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
194/74	194/74	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
medical	medical	JJ	I-NP	O
team	team	NN	I-NP	O
suspects	suspect	VBZ	B-VP	O
that	that	IN	B-SBAR	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
episodic	episodic	JJ	I-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
prompting	prompt	VBG	B-VP	O
multiple	multiple	JJ	B-NP	O
visits	visit	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
D.sen	D.sen	NNP	I-NP	O
Health	Health	NNP	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
from	from	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
and/or	and/or	CC	O	O
ventricular	ventricular	JJ	B-NP	O
pauses	pause	NNS	I-NP	O
.	.	.	O	O

Additional	Additional	JJ	B-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
pursued	pursue	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gehrer	Gehrer	NNP	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
significant	significant	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
on	on	IN	B-PP	O
recent	recent	JJ	B-NP	O
MRA	MRA	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
team	team	NN	I-NP	O
suspects	suspect	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
hypertension-induced	hypertension-induced	JJ	B-NP	O
gut	gut	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
and	and	CC	O	O
microvascular	microvascular	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
preliminary	preliminary	JJ	B-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
addendum	addendum	NN	I-NP	O
including	include	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
final	final	JJ	B-NP	O
diagnoses	diagnosis	NNS	I-NP	O
and	and	CC	O	O
medical	medical	JJ	B-NP	O
followup	followup	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
dictated	dictate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-5694568	1-5694568	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
EMMERLING	EMMERLING	NNP	B-NP	O
,	,	,	O	O
QUINTON	QUINTON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
THON	THON	NNP	B-NP	O
,	,	,	O	O
KERRY	KERRY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5456663	5456663	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/5/07	9/5/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/29/07	4/29/07	CD	B-NP	O

